Skip to main content

MoneyWorks4Me

Gujarat Themis Biosyn informs about clarification

12 Feb 2020 Evaluate

With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Gujarat Themis Biosyn has submitted a copy of clarification.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..